Compared to conventional chemo, ibrutinib has significant increase in blood pressure, 36% having more than 10mmHg increase in SBP at 1 month, sustained to mid term (2-6 months). Despite this appropriate HTN drug initiation or modification not done in 61%.
Hot off the press ❤️🔥
Association between ibrutinib treatment and hypertension
- ibrutinib: Bruton TKI used for multiple malignancies.
- few cardiotoxicities: atrial fibrillation and hypertension
- we studied ibrutinib vs conventional chemotherapies.
https://t.co/EboTWuUExe
One of my favorite things as a program director is calling our new interns on match day
I continue the tradition, 4 recruitment seasons now, of collecting their match day pictures and videos
❤️🥰❤️
Best day ever!
See the compilation:
https://t.co/kLpNcq1feI
Patients with CKD (with or without diabetes) who received dapagliflozin have lower risk of a composite of a sustained decline in the estimated GFR of at least 50%, end-stage kidney disease, or death from renal or CV causes than those who received placebo. #EASD2020
Reminder that taking the time to gently reorient patients who are confused and encephalopathic can be the most important part of a patient’s care plan, especially when the life saving interventions they need are uncomfortable or invasive.
SGLT2 inhibitors should be regarded as neurohormonal antagonists when prescribed for the treatment of heart failure with a reduced ejection fraction. https://t.co/hOyDjqAZDe #AHAJournals
Left atrial scar takes you far in atrial fibrillation by #WhyCMR. In this Danish 🇩🇰 study, left atrial fibrosis was associated with incident #AFib detected by implantable loop recorder during a median of 41 months. https://t.co/RGa6WrZEAA #JACCIMG